Roger L Pang

Array ( [id] => 3660401 [patent_doc_number] => 05627274 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Antisense oligonucleotides which combat aberrant splicing and methods of using the same' [patent_app_type] => 1 [patent_app_number] => 8/453224 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7477 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627274.pdf [firstpage_image] =>[orig_patent_app_number] => 453224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3518078 [patent_doc_number] => 05576427 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-19 [patent_title] => 'Acyclic nucleoside analogs and oligonucleotide sequences containing them' [patent_app_type] => 1 [patent_app_number] => 8/452196 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6657 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/576/05576427.pdf [firstpage_image] =>[orig_patent_app_number] => 452196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3818892 [patent_doc_number] => 05770718 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Gene for APRT from plant tissue' [patent_app_type] => 1 [patent_app_number] => 8/447010 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5916 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770718.pdf [firstpage_image] =>[orig_patent_app_number] => 447010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729747 [patent_doc_number] => 05693536 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Gene therapy with MCC' [patent_app_type] => 1 [patent_app_number] => 8/446549 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 9219 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693536.pdf [firstpage_image] =>[orig_patent_app_number] => 446549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876445 [patent_doc_number] => 05763739 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Transgenic non-human mammals producing BSSL variants' [patent_app_type] => 1 [patent_app_number] => 8/445050 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 30 [patent_no_of_words] => 14685 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763739.pdf [firstpage_image] =>[orig_patent_app_number] => 445050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686188 [patent_doc_number] => 05695979 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Inhibition of reverse transcriptase by phosphorodithioates' [patent_app_type] => 1 [patent_app_number] => 8/411474 [patent_app_country] => US [patent_app_date] => 1995-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6135 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695979.pdf [firstpage_image] =>[orig_patent_app_number] => 411474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3650765 [patent_doc_number] => 05639872 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Human VEGF-specific oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/398945 [patent_app_country] => US [patent_app_date] => 1995-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 11173 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639872.pdf [firstpage_image] =>[orig_patent_app_number] => 398945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828274 [patent_doc_number] => 05731490 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Mutant mouse lacking the expression of interferon regulatory factor 1 (IRF-1)' [patent_app_type] => 1 [patent_app_number] => 8/392292 [patent_app_country] => US [patent_app_date] => 1995-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 42 [patent_no_of_words] => 10912 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731490.pdf [firstpage_image] =>[orig_patent_app_number] => 392292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3650430 [patent_doc_number] => 05684149 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Metal complexes for promoting catalytic cleavage of RNA by transesterification' [patent_app_type] => 1 [patent_app_number] => 8/390240 [patent_app_country] => US [patent_app_date] => 1995-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 9460 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/684/05684149.pdf [firstpage_image] =>[orig_patent_app_number] => 390240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047828 [patent_doc_number] => 05869462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Inhibition of proliferation of vascular smooth muscle cell' [patent_app_type] => 1 [patent_app_number] => 8/389926 [patent_app_country] => US [patent_app_date] => 1995-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 17430 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869462.pdf [firstpage_image] =>[orig_patent_app_number] => 389926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3737529 [patent_doc_number] => 05753434 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Methods and compositions for altering sexual behavior' [patent_app_type] => 1 [patent_app_number] => 8/386495 [patent_app_country] => US [patent_app_date] => 1995-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 23 [patent_no_of_words] => 12518 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753434.pdf [firstpage_image] =>[orig_patent_app_number] => 386495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3647994 [patent_doc_number] => 05683986 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Elaboration of host defense mediators into biological fluids by systemic dsRNA treatment' [patent_app_type] => 1 [patent_app_number] => 8/384396 [patent_app_country] => US [patent_app_date] => 1995-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7300 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/683/05683986.pdf [firstpage_image] =>[orig_patent_app_number] => 384396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688763 [patent_doc_number] => 05691317 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'Antisense oligonucleotides of human regulatory subunit RI-alpha of cAMP dependent protein kinases for the treatment of cancer' [patent_app_type] => 1 [patent_app_number] => 8/383742 [patent_app_country] => US [patent_app_date] => 1995-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 22 [patent_no_of_words] => 9226 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691317.pdf [firstpage_image] =>[orig_patent_app_number] => 383742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3597513 [patent_doc_number] => 05559022 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Liver reserve cells' [patent_app_type] => 1 [patent_app_number] => 8/378762 [patent_app_country] => US [patent_app_date] => 1995-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 9878 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/559/05559022.pdf [firstpage_image] =>[orig_patent_app_number] => 378762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730451 [patent_doc_number] => 05665593 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Antisense oligonucleotides which combat aberrant splicing and methods of using the same' [patent_app_type] => 1 [patent_app_number] => 8/379079 [patent_app_country] => US [patent_app_date] => 1995-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7485 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665593.pdf [firstpage_image] =>[orig_patent_app_number] => 379079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3630867 [patent_doc_number] => 05628144 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Solid matrix priming of seeds with microorganisms and selected chemical treatment' [patent_app_type] => 1 [patent_app_number] => 8/369308 [patent_app_country] => US [patent_app_date] => 1995-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6646 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/628/05628144.pdf [firstpage_image] =>[orig_patent_app_number] => 369308 [rel_patent_id] =>[rel_patent_doc_number] =>)